Protecting Infant Health at the Codex Alimentarius
Members of the IBFAN Working Group on the
Codex Alimentarius participated in three key Codex meetings this
year.
Codex Committee on Food Labelling April 27-30, held in
Ottawa
Labelling of foods obtained through biotechnology.
IBFAN put forward the position (in support of the Consumer's
International standpoint) of mandatory labelling of all foods
containing genetically modified ingredients. Pregnant and lactating
women, infants and young children who need special consideration
should not be put at risk.

Nancy-Jo Peck from IBFAN-GIFA (Geneva Infant Feeding Association)
representing IBFAN at the Codex Alimentarius Commission in Rome
June 28 to July 3
The US initiated the discussion by stating that there was
no scientific evidence to support mandatory labelling and that
"method of production" was not a basis for labelling
but only if "substantial differences" exist in the
food produced through biotechnology and then only the differences
need be labelled and not the fact that the product has been genetically
engineered.
Several key countries (Japan, New Zealand, Brazil) have now
modified their positions and are no longer in support of the
US position, citing consumer pressure and rejection of GM foods
as a reason for this. Mandatory labelling already exists in the
EU and many countries are in strong support of this position
- Norway, Switzerland, Australia, Chile. After considerable discussion,
a working group was established to draft language on this issue.
Health Claims